Selected research
Industry Growth & Trends
Global HIV and AIDS Diagnostics Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global HIV and AIDS Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for HIV and AIDS Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for HIV and AIDS Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for HIV and AIDS Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the HIV and AIDS Diagnostics market include Siemens Healthineers, Bio-Rad, Abbott Laboratories, OraSure TechnologieS, F. Hoffmann-La Roche, Hologic, Abbott, Chembio Diagnostic Systems and BD, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global HIV and AIDS Diagnostics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The HIV and AIDS Diagnostics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HIV and AIDS Diagnostics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HIV and AIDS Diagnostics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global HIV and AIDS Diagnostics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
HIV and AIDS Diagnostics Market by Company
Siemens Healthineers
Bio-Rad
Abbott Laboratories
OraSure TechnologieS
F. Hoffmann-La Roche
Hologic
Abbott
Chembio Diagnostic Systems
BD
Danaher Corporation
HIV and AIDS Diagnostics Segment by Type
Reagent Test Kit
Instrument
Others
HIV and AIDS Diagnostics Segment by Application
Hospitals
Private Diagnostic Laboratories
Academic and Research Institutes
HIV and AIDS Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV and AIDS Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HIV and AIDS Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV and AIDS Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of HIV and AIDS Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Reagent Test Kit
- Instrument
- Others
Applications
- Hospitals
- Private Diagnostic Laboratories
- Academic and Research Institutes
Companies covered
- Siemens Healthineers
- Bio-Rad
- Abbott Laboratories
- OraSure TechnologieS
- F. Hoffmann-La Roche
- Hologic
- Abbott
- Chembio Diagnostic Systems
- BD
- Danaher Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global HIV and AIDS Diagnostics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global HIV and AIDS Diagnostics Market Size by Region (2021-2032)
- 1.4.1 Global HIV and AIDS Diagnostics Market Size by Region (2021-2026)
- 1.4.2 Global HIV and AIDS Diagnostics Market Size by Region (2027-2032)
- 1.5 Key Regions HIV and AIDS Diagnostics Market Size (2021-2032)
- 1.5.1 North America HIV and AIDS Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe HIV and AIDS Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific HIV and AIDS Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.4 South America HIV and AIDS Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa HIV and AIDS Diagnostics Market Size Growth Rate (2021-2032)
2 HIV and AIDS Diagnostics Market by Type
- 2.1 Type Introduction
- 2.1.1 Reagent Test Kit
- 2.1.2 Instrument
- 2.1.3 Others
- 2.2 Global HIV and AIDS Diagnostics Market Size by Type
- 2.2.1 Global HIV and AIDS Diagnostics Market Size Overview by Type (2021-2032)
- 2.2.2 Global HIV and AIDS Diagnostics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global HIV and AIDS Diagnostics Market Size Forecasted by Type (2027-2032)
- 2.3 Global HIV and AIDS Diagnostics Market Size by Regions
- 2.3.1 North America HIV and AIDS Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe HIV and AIDS Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific HIV and AIDS Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America HIV and AIDS Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa HIV and AIDS Diagnostics Market Size Breakdown by Type (2021-2026)
3 HIV and AIDS Diagnostics Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Private Diagnostic Laboratories
- 3.1.3 Academic and Research Institutes
- 3.2 Global HIV and AIDS Diagnostics Market Size by Application
- 3.2.1 Global HIV and AIDS Diagnostics Market Size Overview by Application (2021-2032)
- 3.2.2 Global HIV and AIDS Diagnostics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global HIV and AIDS Diagnostics Market Size Forecasted by Application (2027-2032)
- 3.3 Global HIV and AIDS Diagnostics Market Size by Regions
- 3.3.1 North America HIV and AIDS Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe HIV and AIDS Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific HIV and AIDS Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America HIV and AIDS Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa HIV and AIDS Diagnostics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 HIV and AIDS Diagnostics Industry Trends
- 4.2 HIV and AIDS Diagnostics Industry Drivers
- 4.3 HIV and AIDS Diagnostics Industry Opportunities and Challenges
- 4.4 HIV and AIDS Diagnostics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by HIV and AIDS Diagnostics Revenue (2021-2026)
- 5.2 Global HIV and AIDS Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global HIV and AIDS Diagnostics Key Company Headquarters & Area Served
- 5.4 Global HIV and AIDS Diagnostics Company, Product Type & Application
- 5.5 Global HIV and AIDS Diagnostics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global HIV and AIDS Diagnostics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 HIV and AIDS Diagnostics Players Market Share by Revenue in 2025
- 5.6.3 2025 HIV and AIDS Diagnostics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Siemens Healthineers
- 6.1.1 Siemens Healthineers Company Information
- 6.1.2 Siemens Healthineers Business Overview
- 6.1.3 Siemens Healthineers HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Siemens Healthineers HIV and AIDS Diagnostics Product Portfolio
- 6.1.5 Siemens Healthineers Recent Developments
- 6.2 Bio-Rad
- 6.2.1 Bio-Rad Company Information
- 6.2.2 Bio-Rad Business Overview
- 6.2.3 Bio-Rad HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Bio-Rad HIV and AIDS Diagnostics Product Portfolio
- 6.2.5 Bio-Rad Recent Developments
- 6.3 Abbott Laboratories
- 6.3.1 Abbott Laboratories Company Information
- 6.3.2 Abbott Laboratories Business Overview
- 6.3.3 Abbott Laboratories HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Abbott Laboratories HIV and AIDS Diagnostics Product Portfolio
- 6.3.5 Abbott Laboratories Recent Developments
- 6.4 OraSure TechnologieS
- 6.4.1 OraSure TechnologieS Company Information
- 6.4.2 OraSure TechnologieS Business Overview
- 6.4.3 OraSure TechnologieS HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 OraSure TechnologieS HIV and AIDS Diagnostics Product Portfolio
- 6.4.5 OraSure TechnologieS Recent Developments
- 6.5 F. Hoffmann-La Roche
- 6.5.1 F. Hoffmann-La Roche Company Information
- 6.5.2 F. Hoffmann-La Roche Business Overview
- 6.5.3 F. Hoffmann-La Roche HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 F. Hoffmann-La Roche HIV and AIDS Diagnostics Product Portfolio
- 6.5.5 F. Hoffmann-La Roche Recent Developments
- 6.6 Hologic
- 6.6.1 Hologic Company Information
- 6.6.2 Hologic Business Overview
- 6.6.3 Hologic HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Hologic HIV and AIDS Diagnostics Product Portfolio
- 6.6.5 Hologic Recent Developments
- 6.7 Abbott
- 6.7.1 Abbott Company Information
- 6.7.2 Abbott Business Overview
- 6.7.3 Abbott HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Abbott HIV and AIDS Diagnostics Product Portfolio
- 6.7.5 Abbott Recent Developments
- 6.8 Chembio Diagnostic Systems
- 6.8.1 Chembio Diagnostic Systems Company Information
- 6.8.2 Chembio Diagnostic Systems Business Overview
- 6.8.3 Chembio Diagnostic Systems HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Chembio Diagnostic Systems HIV and AIDS Diagnostics Product Portfolio
- 6.8.5 Chembio Diagnostic Systems Recent Developments
- 6.9 BD
- 6.9.1 BD Company Information
- 6.9.2 BD Business Overview
- 6.9.3 BD HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 BD HIV and AIDS Diagnostics Product Portfolio
- 6.9.5 BD Recent Developments
- 6.10 Danaher Corporation
- 6.10.1 Danaher Corporation Company Information
- 6.10.2 Danaher Corporation Business Overview
- 6.10.3 Danaher Corporation HIV and AIDS Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Danaher Corporation HIV and AIDS Diagnostics Product Portfolio
- 6.10.5 Danaher Corporation Recent Developments
7 North America
- 7.1 North America HIV and AIDS Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 7.3 North America HIV and AIDS Diagnostics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe HIV and AIDS Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 8.3 Europe HIV and AIDS Diagnostics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific HIV and AIDS Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific HIV and AIDS Diagnostics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America HIV and AIDS Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 10.3 South America HIV and AIDS Diagnostics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa HIV and AIDS Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa HIV and AIDS Diagnostics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa HIV and AIDS Diagnostics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst